10 completed, 2 terminated. 10 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 10 | Completed 9, Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Kaleido Biosciences: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Observational Clinical Study to Evaluate COVID-19 Symptoms in "Long Hauler" Patients Who Participated in K031-120 or K032-120 KB109 + Self Supportive Care, Self Supportive Care (SSC) Alone - COVID-19 | Completed | Kaleido Biosciences | 333 | 2021-03-25 | 2021-08-18 | |
| A Clinical Study to Assess the Physiologic Effects of KB109 in Patients With COVID-19 on Gut Microbiota Structure and Function KB109 + Self Supportive Care (SSC), Self Supportive Care (SSC) Alone - Mild-to-Moderate COVID-19 | Not applicable | Completed | Kaleido Biosciences | 49 | 2021-01-12 | 2021-08-13 |
| A Clinical Study to Assess the Effects of KB295 in Patients With Ulcerative Colitis (UC) on Gut Microbiota Structure and Function KB295 - Ulcerative Colitis | Not applicable | Completed | Kaleido Biosciences | 12 | 2020-08-12 | 2022-01-24 |
| A Clinical Study to Assess the Natural History of COVID-19 and Effects of KB109 and Supportive Self-care in Outpatients With Mild-to-moderate COVID-19 KB109 + Self Supportive Care (SSC), Self Supportive Care (SSC) Alone - Mild-to-moderate COVID-19 | Not applicable | Completed | Kaleido Biosciences | 350 | 2020-08-02 | 2021-08-13 |
| UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder KB195 - Urea Cycle Disorder | Phase 2 | Terminated | Kaleido Biosciences | 13 | 2019-09-17 | 2022-01-25 |
| VITORA: Clinical Study to Evaluate the Effect of KB109 on the Gut Microbiome in Subjects Whose Gastrointestinal Tracts Are Colonized With Multiple Drug-resistant Organisms KB109, No intervention - Vancomycin-Resistant Enterococcus, Extended-Spectrum Beta Lactamase-Producing Enterobacteriaceae, or Carbapenem-Resistant Enterobacteriaceae Colonized Subjects | Not applicable | Terminated | Kaleido Biosciences | 3 | 2019-06-27 | 2021-01-22 |
| Clinical Food Study to Evaluate the Effect of KB174 on the Gut Microbiome in Subjects With Well-compensated Cirrhosis KB174, Maltodextrin - Early Cirrhosis | Not applicable | Completed | Kaleido Biosciences | 40 | 2019-02-27 | 2020-05-14 |
| Clinical Food Study to Evaluate the Effect of KB195 on Gut Nitrogen Metabolism in Patients With Urea Cycle Disorders KB195 (a novel mixture of oligosaccharides) - Urea Cycle Disorders | Not applicable | Completed | Kaleido Biosciences | 4 | 2019-01-06 | 2020-01-10 |
| A Clinical Study to Assess the Effect of Novel Glycans on Nitrogen Metabolism of the Gut in Healthy Subjects KB195, Polydextrose, Pullulan - Healthy | Not applicable | Completed | Kaleido Biosciences | 47 | 2017-09-18 | 2020-10-26 |
| A Clinical Study to Assess the Effect of Increasing Intake Amounts of Two Novel Glycans on the Gut Microbiota of Healthy Subjects KB5, SG1, Lactulose - Healthy | Not applicable | Completed | Kaleido Biosciences | 36 | 2017-09-11 | 2020-11-06 |
| A Study to Evaluate the Effect of Diet on the Tolerability of FOS in Healthy Volunteers FOS - Healthy | Not applicable | Completed | Kaleido Biosciences | 7 | 2015-11-01 | 2016-08-30 |
| Study to Evaluate the Tolerability of Prebiotics on the Microbiota GOS, GLOS, FOS - Healthy | Not applicable | Completed | Kaleido Biosciences | 45 | 2015-10-01 | 2016-02-24 |
COVID-19 (3) · Urea Cycle Disorders, Inborn (2) · Colitis, Ulcerative (1) · Fibrosis (1) · Ornithine Carbamoyltransferase Deficiency Disease (1)
Single Person (3) · maltodextrin (2) · Lactulose (1) · polydextrose (1) · pullulan (1)
United States (10) · Ireland (2) · Switzerland (2) · Belgium (1) · Germany (1) · Spain (1) · Turkey (Türkiye) (1) · United Kingdom (1)
Mark Wingertzahn, PhD (8) · Mark Wingertzahn (1)